PMC:7205724 / 17476-17707
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
599 | 19-24 | Species | denotes | human | Tax:9606 |
613 | 108-113 | Species | denotes | human | Tax:9606 |
618 | 169-189 | Disease | denotes | autoimmune disorders | MESH:D001327 |
619 | 193-222 | Disease | denotes | primary antibody deficiencies | MESH:D000081207 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T135 | 201-209 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T123 | 169-189 | Disease | denotes | autoimmune disorders | http://purl.obolibrary.org/obo/MONDO_0007179 |
T124 | 193-222 | Disease | denotes | primary antibody deficiencies | http://purl.obolibrary.org/obo/MONDO_0015517 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T217 | 3-4 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T218 | 19-24 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T219 | 95-96 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T220 | 108-113 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
LitCovid-sample-PD-IDO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T70 | 114-122 | http://purl.obolibrary.org/obo/OGMS_0000031 | denotes | diseases |
T71 | 180-189 | http://purl.obolibrary.org/obo/OGMS_0000045 | denotes | disorders |
LitCovid-sample-PD-NCBITaxon
Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
---|---|---|---|---|---|
T165 | 19-24 | Species | denotes | human | NCBItxid:9606 |
T166 | 108-113 | Species | denotes | human | NCBItxid:9606 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T143 | 36-223 | Sentence | denotes | IVIG is an immunomodulatory treatment currently useful for a variety of human diseases that share an idiopathic origin, ranging from autoimmune disorders to primary antibody deficiencies. |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
---|---|---|---|---|---|
599 | 19-24 | Species | denotes | human | Tax:9606 |
613 | 108-113 | Species | denotes | human | Tax:9606 |
618 | 169-189 | Disease | denotes | autoimmune disorders | MESH:D001327 |
619 | 193-222 | Disease | denotes | primary antibody deficiencies | MESH:D000081207 |
LitCovid-sample-Enju
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T65863 | 3-4 | DT | denotes | a |
T68527 | 5-10 | JJ | denotes | large |
T83960 | 11-15 | NN | denotes | pool |
T57480 | 16-18 | IN | denotes | of |
T98962 | 19-24 | JJ | denotes | human |
T50450 | 25-35 | NNS | denotes | antibodies |
T12037 | 36-40 | NN | denotes | IVIG |
T52317 | 41-43 | VBZ | denotes | is |
T83276 | 44-46 | DT | denotes | an |
T47689 | 47-63 | JJ | denotes | immunomodulatory |
T32201 | 64-73 | NN | denotes | treatment |
T26744 | 74-83 | RB | denotes | currently |
T6595 | 84-90 | JJ | denotes | useful |
T61951 | 91-94 | IN | denotes | for |
T78252 | 95-96 | DT | denotes | a |
T96672 | 97-104 | NN | denotes | variety |
T75647 | 105-107 | IN | denotes | of |
T64366 | 108-113 | JJ | denotes | human |
T37666 | 114-122 | NNS | denotes | diseases |
T30663 | 123-127 | WDT | denotes | that |
T71611 | 128-133 | VBP | denotes | share |
T4369 | 134-136 | DT | denotes | an |
T95969 | 137-147 | JJ | denotes | idiopathic |
T35011 | 148-154 | NN | denotes | origin |
T94518 | 154-155 | -COMMA- | denotes | , |
T34533 | 156-163 | VBG | denotes | ranging |
T57537 | 164-168 | IN | denotes | from |
T47481 | 169-179 | JJ | denotes | autoimmune |
T10634 | 180-189 | NNS | denotes | disorders |
T96539 | 190-192 | TO | denotes | to |
T18270 | 193-200 | JJ | denotes | primary |
T92790 | 201-209 | NN | denotes | antibody |
T91348 | 210-222 | NNS | denotes | deficiencies |
T23275 | 224-228 | RB | denotes | Also |
T97483 | 228-229 | -COMMA- | denotes | , |
R11871 | T83960 | T65863 | arg1Of | pool,a |
R81126 | T83960 | T68527 | arg1Of | pool,large |
R87985 | T83960 | T57480 | arg1Of | pool,of |
R85206 | T50450 | T57480 | arg2Of | antibodies,of |
R95689 | T50450 | T98962 | arg1Of | antibodies,human |
R7397 | T12037 | T52317 | arg1Of | IVIG,is |
R59827 | T32201 | T52317 | arg2Of | treatment,is |
R45922 | T32201 | T83276 | arg1Of | treatment,an |
R32666 | T32201 | T47689 | arg1Of | treatment,immunomodulatory |
R38821 | T32201 | T26744 | arg1Of | treatment,currently |
R80185 | T26744 | T6595 | arg1Of | currently,useful |
R62385 | T6595 | T61951 | arg1Of | useful,for |
R78431 | T96672 | T61951 | arg2Of | variety,for |
R3964 | T96672 | T78252 | arg1Of | variety,a |
R72167 | T96672 | T75647 | arg1Of | variety,of |
R82814 | T37666 | T75647 | arg2Of | diseases,of |
R55274 | T37666 | T64366 | arg1Of | diseases,human |
R31515 | T37666 | T30663 | arg1Of | diseases,that |
R12726 | T37666 | T71611 | arg1Of | diseases,share |
R20851 | T35011 | T71611 | arg2Of | origin,share |
R86274 | T35011 | T4369 | arg1Of | origin,an |
R95215 | T35011 | T95969 | arg1Of | origin,idiopathic |
R10701 | T32201 | T94518 | arg1Of | treatment,"," |
R19665 | T32201 | T34533 | arg1Of | treatment,ranging |
R89530 | T34533 | T57537 | arg1Of | ranging,from |
R77337 | T10634 | T57537 | arg2Of | disorders,from |
R63281 | T10634 | T47481 | arg1Of | disorders,autoimmune |
R45693 | T34533 | T96539 | arg1Of | ranging,to |
R65268 | T91348 | T96539 | arg2Of | deficiencies,to |
R94792 | T91348 | T18270 | arg1Of | deficiencies,primary |
R91107 | T91348 | T92790 | arg1Of | deficiencies,antibody |
LitCovid-sample-PD-FMA
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T135 | 201-209 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
LitCovid-sample-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T119 | 169-189 | Disease | denotes | autoimmune disorders | http://purl.obolibrary.org/obo/MONDO_0007179 |
T120 | 193-222 | Disease | denotes | primary antibody deficiencies | http://purl.obolibrary.org/obo/MONDO_0015517 |
LitCovid-sample-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T4 | 169-189 | Phenotype | denotes | autoimmune disorders | http://purl.obolibrary.org/obo/HP_0002960 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T143 | 36-223 | Sentence | denotes | IVIG is an immunomodulatory treatment currently useful for a variety of human diseases that share an idiopathic origin, ranging from autoimmune disorders to primary antibody deficiencies. |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T4 | 169-189 | Phenotype | denotes | autoimmune disorders | http://purl.obolibrary.org/obo/HP_0002960 |